Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
University of Miami
City of Hope Medical Center
Thomas Jefferson University
Roswell Park Cancer Institute
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
SWOG Cancer Research Network
M.D. Anderson Cancer Center
Takeda
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
National Cancer Institute (NCI)
Northside Hospital, Inc.
Barbara Ann Karmanos Cancer Institute
SWOG Cancer Research Network
University of California, San Francisco
Northside Hospital, Inc.
Northwestern University
OHSU Knight Cancer Institute
SWOG Cancer Research Network
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center